UNSPSC 85522181: Bypass hemiazygos vein to upper vein with synthetic substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass hemiazygos vein to upper vein with synthetic substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05114JY

UNSPSC 85522181 Bypass hemiazygos vein to upper vein with synthetic substitute, percutaneous endoscopic approach is a Commodity code that shows little relevant recent activity. The code's technical surgical descriptor—a specific vascular bypass procedure—does not align with the state and local procurement opportunities currently posted under this code. The six recent solicitations include independent medical evaluation services for pension disability determinations, surgical benefit carve-out programs for municipal employee health plans, occupational medical surveillance for ferry workers, emergency and specialty medical services for detained youth, pharmacy benefit management administration, and temporary health professional staffing for a county health system. None of these opportunities involves the procurement of vascular surgery services, surgical implants, or medical devices specific to hemiazygos vein bypass procedures. The mismatch suggests either a classification error in the state and local procurement system's tagging or that this code is not routinely used for genuine state and local contracting activity in this commodity family.

The issuing bodies across the misaligned opportunities span city retirement offices, municipal HR departments, state transportation agencies, county juvenile justice authorities, county human resources divisions, and county health systems—a mix typical of state and local healthcare and benefits administration. Geographic activity includes Arizona, California, Washington State, Texas, and Florida. Without opportunities genuinely soliciting under the code's stated scope, no representative recent procurement can be cited as decision-relevant for vendors in vascular surgery or related medical device supply.